Home
NICE Guidance
NICE Advice
Medtech innovation briefings

The Prosigna gene expression profiling assay for assessing long‑term risk of breast cancer recurrence

Medtech innovation briefing [MIB27] Published: 25 March 2015

Advice

This advice has been updated and replaced by NICE diagnostics guidance 34.